Servier acquires Day One Biopharma

Servier agreed to acquire Day One Biopharma. Reported deal value: $2.5B. Status: Pending. Sector: medical. Target headquarters context: Brisbane, California, United States.

This page summarizes publicly available information about the transaction as of 2026-03-10. Figures and status may change as filings and press coverage update.

Servier to Acquire Day One Biopharmaceuticals in $2.5 Billion Transaction Servier to Acquire Day One Biopharmaceuticals in $2.5 Billion Transaction Baker McKenzie has advised Servier , and Fenwick & West has advised Day One Biopharmaceuticals . Servier , an independent international pharmaceutical group, has entered into a definitive agreement to… Standard 1 Year Membership Required You must be a Standard 1 Year member to access this content